Your browser doesn't support javascript.
loading
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma.
Song, Xinhua; Liu, Xianqiong; Wang, Haichuan; Wang, Jingxiao; Qiao, Yu; Cigliano, Antonio; Utpatel, Kirsten; Ribback, Silvia; Pilo, Maria G; Serra, Marina; Gordan, John D; Che, Li; Zhang, Shanshan; Cossu, Antonio; Porcu, Alberto; Pascale, Rosa M; Dombrowski, Frank; Hu, Hongbo; Calvisi, Diego F; Evert, Matthias; Chen, Xin.
Afiliação
  • Song X; Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
  • Liu X; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California.
  • Wang H; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California.
  • Wang J; School of Pharmacy, Hubei University of Chinese Medicine Wuhan, Hubei, China.
  • Qiao Y; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California.
  • Cigliano A; Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Utpatel K; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California.
  • Ribback S; Beijing University of Chinese Medicine, Beijing, China.
  • Pilo MG; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California.
  • Serra M; Department of Oncology, Beijing Hospital, Beijing, China.
  • Gordan JD; Institute of Pathology, University of Greifswald, Greifswald, Germany.
  • Che L; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Zhang S; Institute of Pathology, University of Greifswald, Greifswald, Germany.
  • Cossu A; Institute of Pathology, University of Greifswald, Greifswald, Germany.
  • Porcu A; Institute of Pathology, University of Greifswald, Greifswald, Germany.
  • Pascale RM; Department of Medicine, University of California, San Francisco, California.
  • Dombrowski F; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California.
  • Hu H; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California.
  • Calvisi DF; Unit of Pathology, Azienda Ospedaliero Universitaria Sassari, Sassari, Italy.
  • Evert M; Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
  • Chen X; Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
Clin Cancer Res ; 25(1): 403-413, 2019 01 01.
Article em En | MEDLINE | ID: mdl-30084835
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colangiocarcinoma / Inibidores de Proteínas Quinases / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina / Serina-Treonina Quinases TOR Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colangiocarcinoma / Inibidores de Proteínas Quinases / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina / Serina-Treonina Quinases TOR Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China